Location History:
- Songtan, KR (1998)
- Pyongtak, KR (1999)
- Kyungki-do, KR (2000 - 2007)
- Hwaseong-si, KR (2010)
Company Filing History:
Years Active: 1998-2010
Title: The Innovative Contributions of Inventor Sun-Hwan Lee
Introduction: Sun-Hwan Lee, based in Kyungki-do, South Korea, is an accomplished inventor known for his significant contributions to pharmaceutical innovations. With a total of nine patents to his name, Lee has made remarkable strides in the field of medicinal chemistry, particularly focusing on antiviral and antitumor agents.
Latest Patents: Among his latest patents are two notable inventions. The first is the "Use of Pyrimidinedione Derivative for Preventing or Treating Hepatitis C." This patent highlights a pyrimidinedione derivative that exhibits excellent inhibitory activity against the hepatitis C virus, offering a potential therapeutic avenue for this widespread infection. The second patent is for "9-Aminoacridine Derivatives and Process for the Preparation Thereof." This invention pertains to a new 9-aminoacridine derivative showcasing prominent antitumor activity while maintaining low toxicity, making it a promising candidate for cancer treatment.
Career Highlights: Sun-Hwan Lee has worked with reputable organizations, including Samjin Pharmaceutical Co., Ltd. and Samjin Pharmaceutical Co., Ltd. (note the corrected spelling). His tenure at these companies has played a crucial role in advancing drug development and fostering innovation within the pharmaceutical sector.
Collaborations: Throughout his career, Lee has collaborated with talented colleagues, including Eui-Hwan Cho and Sun-Gan Chung, the latter being a prominent female researcher. These collaborations have been instrumental in expanding the potential applications of his inventions and enhancing research outcomes in their respective fields.
Conclusion: In conclusion, Sun-Hwan Lee stands out as a pivotal figure in the realm of medicinal invention. His innovative patents not only demonstrate his commitment to addressing significant health challenges, such as hepatitis C and cancer, but also reflect the collaborative spirit of scientific research. As the pharmaceutical landscape continues to evolve, Lee's contributions will undoubtedly leave a lasting impact on the industry.